Ma et al., 2021 - Google Patents
Metal–organic frameworks towards bio-medical applicationsMa et al., 2021
View PDF- Document ID
- 1058591592437266349
- Author
- Ma X
- Lepoitevin M
- Serre C
- Publication year
- Publication venue
- Materials Chemistry Frontiers
External Links
Snippet
This mini review summarises the progress in the field of MOFs and their use in biomedical applications, from their early discovery and conception, to more recent achievements including promising in vivo applications. It looks to identify in detail the main advantages and …
- 230000001988 toxicity 0 abstract description 27
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
- A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ma et al. | Metal–organic frameworks towards bio-medical applications | |
| Duman et al. | Applications of nanoscale metal–organic frameworks as imaging agents in biology and medicine | |
| Yang et al. | Metal‐organic framework‐based cancer theranostic nanoplatforms | |
| Kim et al. | Post-synthetic modifications in porous organic polymers for biomedical and related applications | |
| Zhou et al. | Nanoscaled metal‐organic frameworks for biosensing, imaging, and cancer therapy | |
| Lu et al. | Nanoscale metal–organic frameworks for therapeutic, imaging, and sensing applications | |
| Gulzar et al. | Nano-graphene oxide-UCNP-Ce6 covalently constructed nanocomposites for NIR-mediated bioimaging and PTT/PDT combinatorial therapy | |
| Yang et al. | Multifunctional and stimuli‐responsive magnetic nanoparticle‐based delivery systems for biomedical applications | |
| Lan et al. | The role of nanoparticles and nanomaterials in cancer diagnosis and treatment: a comprehensive review | |
| Arun Kumar et al. | Two‐dimensional metal organic frameworks for biomedical applications | |
| Dong et al. | Fabrication of PEGylated graphitic carbon nitride quantum dots as traceable, pH-sensitive drug delivery systems | |
| Li et al. | Smart nanomedicine agents for cancer, triggered by pH, glutathione, H2O2, or H2S | |
| Shanmugam et al. | Multifunctional CuO/Cu2O truncated nanocubes as trimodal image-guided near-infrared-III photothermal agents to combat multi-drug-resistant lung carcinoma | |
| Sharker et al. | Target delivery of β-cyclodextrin/paclitaxel complexed fluorescent carbon nanoparticles: externally NIR light and internally pH sensitive-mediated release of paclitaxel with bio-imaging | |
| Liu et al. | Fluorescence-enhanced covalent organic framework nanosystem for tumor imaging and photothermal therapy | |
| Song et al. | Zeolitic imidazolate metal organic framework-8 as an efficient pH-controlled delivery vehicle for zinc phthalocyanine in photodynamic therapy | |
| Fan et al. | Anticancer drug delivery systems based on inorganic nanocarriers with fluorescent tracers | |
| Liu et al. | A smart tumor microenvironment responsive nanoplatform based on upconversion nanoparticles for efficient multimodal imaging guided therapy | |
| Liu et al. | Metal‐Organic Frameworks‐Based Fluorescent Nanocomposites for Bioimaging in Living Cells and in vivo | |
| Zhao et al. | Bimetallic zeolitic imidazolate framework as an intrinsic two-photon fluorescence and pH-responsive MR imaging agent | |
| Chen et al. | Research advances and applications of ZIF-90 metal–organic framework nanoparticles in the biomedical field | |
| Yu et al. | Iron‐MOFs for Biomedical Applications | |
| CN104474556A (en) | Application of carbon dot as anti-tumor medicine carrier | |
| Gong et al. | Nanoscale metal–organic frameworks as a photoluminescent platform for bioimaging and biosensing applications | |
| Wu et al. | Iron oxide nanoparticles protected by NIR-active multidentate-polymers as multifunctional nanoprobes for NIRF/PA/MR trimodal imaging |